RxDoctor Payments Data

Carol Pinder, APRN

Family · Jupiter, FLNPI 1154365476

Payments from drug & device makers

$1,640in general payments, 2019–2025

Across 88 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$386
  • Novo Nordisk$286
  • Pfizer$149
  • AstraZeneca$136
  • Lilly USA, LLC$121
  • GSK$108
  • plus $454 from 13 others

What the payments were for

  • Food & beverage$1,60398%
  • Education$382%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,640 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$18,910
Medicare patients
67
Services billed
362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$31,906
MounjaroTirzepatide25$26,054
JanuviaSitagliptin Phosphate13$18,680
EliquisApixaban24$17,396
LamictalLamotrigine11$4,611
Albuterol Sulfate HfaAlbuterol Sulfate77$1,979
Gabapentin82$1,446
Rosuvastatin Calcium101$1,381
Atorvastatin Calcium176$1,064
Ibuprofen69$818
Lisinopril140$762
Levothyroxine Sodium108$695
Diclofenac Sodium25$654
Isosorbide Dinitrate14$644
Losartan Potassium114$565

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$286$31,90617 claims
Lilly USA, LLCMounjaro$121$26,05425 claims
PfizerEliquis$149$17,39624 claims
GSKLamictal$108$4,61111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 14,618 family providers in Florida.

Other family in Jupiter

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →